|51.22||-1.04 / -1.99%|
Data as of 3:59pm ET
|51.26||+0.04 / +0.08%|
The 10 analysts offering 12-month price forecasts for Isis Pharmaceuticals Inc have a median target of 59.50, with a high estimate of 70.00 and a low estimate of 9.00. The median estimate represents a +16.17% increase from the last price of 51.22.
The current consensus among 10 polled investment analysts is to Hold stock in Isis Pharmaceuticals Inc. This rating has held steady since February, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.